BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3040109)

  • 1. The reduction of anti-tumour diaziridinyl benzoquinones.
    Butler J; Hoey BM; Lea JS
    Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
    Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
    King CL; Wong SK; Loo TL
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Friedman RD; Bachur NR
    Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.
    Qiu X; Forman HJ; Schönthal AH; Cadenas E
    J Biol Chem; 1996 Dec; 271(50):31915-21. PubMed ID: 8943236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radicals in quinone containing antitumor agents. The nature of the diaziquone (3,6,-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone) free radical.
    Gutierrez PL; Bachur NR
    Biochim Biophys Acta; 1983 Jul; 758(1):37-41. PubMed ID: 6305426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
    Gutierrez PL
    Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ)--I.
    Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1989 Mar; 38(6):923-7. PubMed ID: 2930592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
    Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
    Hartley JA; Berardini M; Ponti M; Gibson NW; Thompson AS; Thurston DE; Hoey BM; Butler J
    Biochemistry; 1991 Dec; 30(50):11719-24. PubMed ID: 1751490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
    Gutierrez PL; Biswal S; Nardino R; Biswal N
    Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
    Gutierrez PL; Fox BM; Mossoba MM; Bachur NR
    Mol Pharmacol; 1984 Nov; 26(3):582-6. PubMed ID: 6092903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
    Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
    J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the structural and cytotoxic activity of novel 2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone analogues.
    Dzielendziak A; Butler J; Hoey BM; Lea JS; Ward TH
    Cancer Res; 1990 Apr; 50(7):2003-8. PubMed ID: 2156610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaziquone as a potential agent for photoirradiation therapy: formation of the semiquinone and hydroxyl radicals by visible light.
    Mossoba MM; Gutierrez PL
    Biochem Biophys Res Commun; 1985 Oct; 132(1):445-52. PubMed ID: 2998365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
    Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
    Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.
    Ordoñez ID; Cadenas E
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):481-90. PubMed ID: 1530580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemical reduction of diaziquone: products and free radical intermediates.
    Gutierrez PL; Balachandran Nayar MS; Nardino R; Callery PS
    Chem Biol Interact; 1987; 64(1-2):23-37. PubMed ID: 2826025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diaziquone-glutathione conjugates: characterization and mechanisms of formation.
    Gutierrez PL; Siva S
    Chem Res Toxicol; 1995; 8(3):455-64. PubMed ID: 7578933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.